Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study by Sohier Yahia et al.
Yahia et al. BMC Endocrine Disorders 2012, 12:22
http://www.biomedcentral.com/1472-6823/12/22RESEARCH ARTICLE Open AccessLeptin, insulin and thyroid hormones in a cohort
of Egyptian obese Down syndrome children: a
comparative study
Sohier Yahia1, Reham M EL-farahaty2, Amany K El-Hawary1*, Mona A El-hussiny2, Hanaa Abdel-maseih2,
Faeza El-Dahtory3 and Abdel-Hady El-Gilany4Abstract
Background: Obesity is a major worldwide health problem. It is commonly observed in Down syndrome
individuals than in the general population. The reason for increased risk of obesity in DS is unclear.
The current study was designed to clarify differences in some obesity- related hormones in a group of prepubertal
Down syndrome children.
Methods: Thirty six Egyptian children with Down syndrome were enrolled in this study, divided according to their
body mass index (BMI) into 23 obese and13 non obese. Another group of 43 non Down children were recruited,
they were divided according to their BMI into 20 patients having simple obesity and 23 non obese, as control
groups. Fasting blood samples were collected for estimation of fasting blood glucose (FBG), insulin, leptin, free
thyroxin (FT4), thyroid stimulating hormones (TSH) and creatine kinase (CK). Insulin resistance was assessed by
Homeostasis Model Assessment method (HOMA-IR). The ratio of leptin to BMI (LEP/BMI) was used as an index of
leptin resistance.
Results: Median values of FBG, insulin, and HOMA-IR were significantly higher in Down versus non Down groups,
while median values of leptin and leptin resistance were non-significantly different among Down versus non Down
groups. Median TSH values were non- significantly different between obese Down and obese non Down. Although
the median values of TSH and FT4 were within normal range in Down groups, four cases of subclinical
hypothyroidism were encountered. Leptin levels were correlated with insulin and IR but not with TSH in Down
groups.
Conclusion: Increased circulating leptin, a marker of leptin resistance in obese children with Down syndrome
seems to be similar to that in children with simple obesity. Elevated FBG and insulin in obese Down children
highlights the presence of early IR. Associated myopathy evidenced by mildly elevated CK levels could be an added
factor for obesity in such group of patients.
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Down syndrome (DS, trisomy 21) is the most common
chromosomal abnormality affecting live-born infants.
Children with DS demonstrate an increased risk of de-
veloping various endocrine disorders, such as hypo-
thyroidism, diabetes mellitus and childhood obesity [1].
Unique characteristics of this syndrome such as reduced
resting metabolic rates [2] or decreased physical activity
[3] and increased risk of diabetes or hypothyroidism [4]
may play a role in the development of obesity. In
addition, children with DS may have a tendency to
overeat, since the cerebral regions that are responsible
for weight regulation may be damaged [5,6] moreover,
there is incapacity to do long physical exercise in DS
individuals because the effort can be quickly perceived as
painful, difficult and without sense for them, which con-
tributes to adoption of a sedentary lifestyle [7].
Obesity is known to increase the risk of morbidity and
mortality in DS persons [8]. Obesity is characterized by
an increase of adipose tissue mass [9]. Adipocytes se-
crete leptin hormone, which acts in the hypothalamus to
suppress appetite and control body weight [10]. In
addition, insulin regulates energy homeostasis through
control of appetite and energy expenditure [11]. Both
hormones rise in direct proportion to adipose mass, they
cross blood brain barrier and have receptors in the arcu-
ate nucleus [12].
Although leptin production is positively correlated
with the percentage of body fat, it is postulated that
obese individuals, with hyperleptinemia, have some de-
gree of leptin resistance [10]. It is unclear whether this
mechanism is similar in children with DS.
The aim of the work
The current study was designed to clarify differences in
some obesity- related hormones in a group of prepuber-
tal Down syndrome children.
Methods
The present study was conducted on two groups: group
I, comprised 36 children having DS confirmed as tri-
somy 21 by chromosomal study their age ranged from 2
to 10 years. All were living within their families and were
of same socioeconomic class, they were not assigned for
special diet regimen. They were recruited from out-
patient clinic of Pediatric Genetic Unit, Mansoura Uni-
versity Children Hospital; they were enrolled in physical
and speech therapy programs to help their motor skills
and language development. They were divided according
to BMI into; non obese Down (NOD) group of 13 cases,
of whom 7 males and 6 females with BMI percentiles
> 5th to ≤ 85th, their ages ranged from 2 to 8 years, and
the obese Down (OD) group of 23 cases, of whom 13
males and 10 females, their age ranged from 2.5 to 10years, with BMI percentiles > 95th. Group II comprised
43 children, without DS to act as a control group. They
were divided according to BMI into; 20 obese non Down
patients (OND) including 12 males and 8 females to rep-
resent simple obesity they were recruited from Endo-
crinology unit, Mansoura University Children Hospital.
Their age ranged from 2.8 to 11 years, and 23 non obese
non Down (NOND) healthy children including 12 males
and 11 females, their age ranged from 2 to 10 years. The
study was approved by the research ethics committee of
Mansoura University. All groups are subjected to thor-
ough history and clinical examination including the
presence of acanthosis nigricans. Anthropometric data
were collected as part of an ongoing research program
ascertaining standing height to the nearest 0.1cm in bare
feet using portable Harpender stadiometer and weight to
the nearest 0.1kg using digital weight scale, the measure-
ments were repeated twice and the average was
recorded. BMI was calculated for groups as weight (kg)
divided by height (m) squared [13]. We excluded chil-
dren who had started pubertal development according
to Tanner and Whitehouse staging (1976) [14] to avoid
hormonal changes induced by puberty. Patients having
chronic conditions affecting growth or energy balance
and children who already were taking thyroxine, corti-
costeroids or immunosuppressive drugs were excluded.
Laboratory data: Blood samples were collected after
a-12 hours overnight fast for estimation of fasting blood
glucose (FBG), insulin, leptin, Thyroid stimulating
hormone (TSH), Free thyroxin (FT4) and creatine kinase
(CK). FBG was estimated by liquizyme GOD- PAP sup-
plied by Human, Germany [15]; serum insulin by chemi-
lumeinescent immunometric assay using IMMULITEW
1000 supplied by Siemenes Healthcare Diagnostics, USA
[16], serum leptin by enzyme-linked immunosorbent
assay (ELISA) supplied by DRG GmbH, Germany [10]
and serum CK levels using CK-NAC liquid, UV kinetic
method (Human,Germany) [15]; and serum TSH and
FT4 concentrations by electrochemiluminescence im-
munoassay (ECLIA) using Elecsys 2010, Roch Diagnos-
tics GmbH, Germany [17]. Insulin resistance (IR) was
calculated according to homeostasis model assessment-
estimated insulin resistance (HOMA-IR), through the
formula: FBG (mmol/L) x fasting insulin (μIU/ml)/22.5
[18]. The ratio of leptin to BMI (LEP/BMI) was used as
an index of leptin resistance (Leptin- R). This index
measures leptin levels while controlling for the contribu-
tion of BMI [19].
Statistical analysis
Data were analyzed using SPSS statistical package version
16. Categorical variable (sex) was presented as number and
percent. Chi square test was used for comparison between
groups. Numerical variables were tested for normality by
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ric in distribution. So Kruskal Wallis was used for com-
parison between four groups while, Mann Whitney was
used for comparison between two groups. Spearman's
correlation coefficient was used to test the correlation
between variables within each group of patients. P≤0.05
was considered to be statistically significant.
Results
Table 1 showed comparison between studied groups











Median 6.2ab 5.2 ac
Range 5.2-6.8 4.4-6.3
Insulin (uU/ml)
Median 20 ab 7 ac
Range 9-56 4-10
HOMA-IR
Median 5.8 ab 1.56 ac
Range 2.2-8.35 0.9-2.57
Leptin (ng/ml)
Median 18 a 3 a
Range 11-36 1.8-10
leptin R
Median 0.68 a 0.21 a
Range 0.4-1.26 0.13-0.46
TSH (uU/ml)
Median 3 2.8 c
Range 0.85-7.30 1-5.7
FT4 (pmol/L)
Median 16 b 16.2
Range 12-22 13-20
CK (U/L)
Median 60 b 50 c
Range 12-193 35-130
OD: Obese Down. NOD: Non obese Down.
OND: Obese non Down. NOND: Non obese non Down.
#: Kruskal wallis test was used except for association with sex, Chi square test was u
a: Significant P(MW)<0.05, comparing OD Vs NOD groups.
b: Significant P(MW)<0.05, comparing OD Vs OND groups.
c: Significant P(MW)<0.05, comparing NOD Vs NOND groups.CK. Regarding age and sex there were no significant dif-
ference between four groups (P= 0.160, 0. 962).
Considering Down groups; OD group showed signifi-
cantly higher median values of FBG, insulin, HOMA-IR,
leptin and leptin-R compared with NOD group (P<
0.001), while no significant differences as regard TSH,
FT4 and CK.
Considering the two obese groups, OD group showed
significantly higher median values of FBG, insulin, HOMA-
IR, FT4 and CK compared with OND group (p< 0.001).








5.6 b 4.6 c <0.001
2.7-6.10 4-5.2
10.9 b 3.8 c <0.001
4.6-18.5 2-6






3.3 1.3 c <0.001
0.7-2.7 0.4-3.0
12 b 14 <0.001
10.4-14.8 12.5-15
29 b 30 c <0.001
18-47 24-50
sed.
Table 2 Correlations between some studied parameters in each group
Parameters OD NOD OND NOND
r P R p r p r p
Age:
and leptin 0.913 <0.001 0.557 0.048 0.510 0.021 0.947 <0.001
and leptin -R 0.925 <0.001 0.089 0.772 0.440 0.052 0.792 <0.001
and Insulin 0.575 0.004 0.305 0.310 0.310 0.183 0.795 <0.001
Leptin:
and insulin 0.619 0.002 0.722 0.005 0.336 0.148 0.775 <0.001
and HOMA-IR 0.608 0.002 0.626 0.022 0.402 0.079 0.806 <0.001
and leptin- R 0.969 <0.001 0.709 0.007 0.985 <0.001 0.899 <0.001
and TSH 0.170 0.438 0.472 0.104 0.222 0.347 0.645 0.001
CK and TSH 0.636 0.001 0.194 0.524 0.371 0.108 0.433 0.039
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tin and leptin-R between both groups. At the same time,
among the two normal BMI groups (>5to ≤85 percentiles),
NOD group showed significantly higher but still within
reference range median values of FBG, insulin, HOMA-IR,
TSH, FT4 and CK compared with NOND group (P =
0.003, <0.001), while no significant differences as regard
leptin and leptin-R were present between both groups.
Table 2 showed correlations between studied parameters
in each group. Significant positive correlations were
observed between age and each of leptin, leptin-R and in-
sulin in both OD and NOND groups and only between
age and leptin in OND group. Also significant positive
correlation were observed between leptin and each of in-
sulin, HOMA-IR and leptin resistance in OD, NOD and
NOND groups, while in OND group significant positive
correlation were observed only between leptin and leptin
–R, but no correlation were found between leptin and
TSH . As regard CK there were significant positive correl-
ation with TSH in both OD and NOND groups.
Discussion
The main findings of the present study are the associ-
ation between hyperinsulinemia, impaired fasting glu-
cose and obesity in obese Down children, that could
make them at higher risk to develop IRS. Also there is
elevation of leptin and leptin-R median values in both
OD and NOD groups with normal thyroid profile in
down children. However four cases of subclinical
hypothyroidism associated with CK above 90 U/L values
were observed. This study was one of the few to report
median and range values of some hormones related to
obesity in a cohort of Egyptian DS obese and non obese
prepubertal children.
IR in children with DS
One of the characteristics of the person with trisomy 21
is the propensity for becoming obese [2]. IR is the mostcommon metabolic alteration related to obesity [20].
Considering the upper limit of FBG up to 5.55 mmol/L
[21], normal fasting range for insulin varies from 5 to 15
μIU/ml [22] and fasting insulin greater than 15μIU/ml
indicated IR [12]. This study showed significant higher
median values of FBG, insulin and IR (assisted by
HOMA-IR) in Down (OD, NOD) versus non Down
(OND, NOND) groups with highest median values in
OD group. This could be attributed to high levels of adi-
pose tissue (which is more central than peripheral) in
such children [22,23] and the fact that central adiposity
is more associated with IR [22]. Magge et al. [24]
observed significantly higher percent body fat, non sig-
nificantly higher insulin and glucose in children with DS
than unaffected siblings, while no significant difference
in HOMA-IR. It was suggested previously in small size
study, (15 cases, including one prepubertal child with
DS) that increased HOMA-IR and high rate of glucose
production indicated presence of peripheral and hepatic
IR in adolescent with DS [22].
Considering one of the two definitions of IR syndrome
in children: [1] the presence of any three or more of
hyperinsulinemia, overweight, high systolic blood pres-
sure, high triglycerides, low HDL-C and impaired fasting
glucose; and [2] the presence of hyperinsulinemia and at
least two of the other five risk factors [25]. Our study
reported an association between hyperinsulinemia,
impaired fasting glucose and obesity in obese Down chil-
dren, that could make them at higher risk to develop se-
vere metabolic complications. In contrary Flore et al.,
2008 [26] could not display IR in a group of young non
obese adults with DS.
Leptin, leptin-R & obesity in DS children
Considering leptin and leptin-R, a higher median value
of leptin in OD children was observed in this study,
however, no significant difference in leptin and leptin -R
were observed between OD versus OND, indicating an
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resistance in obese children irrespective to the cause of
obesity. This was in contrary to the suggestion of pres-
ence of genetic basis for obesity (three copies of chromo-
some 21) that might be a cause of more severe leptin
resistance in DS [24]. Previously Considine et al. [10]
concluded that obese individuals have higher leptin levels
than normal weight individuals, and obesity is associated
with leptin resistance. This belief is in harmony with our
results that showed positive correlation between leptin
and leptin-R in obese groups (OD, OND).
Insulin leptin interrelationship
Consistent with insulin/leptin arcuate nucleus of the
hypothalamus axis, insulin and glucose appear to stimu-
late leptin secretion in adipocytes. In response, leptin
decreases insulin secretion via direct action on leptin
receptors in pancreatic B-cells while enhancing their
actions and consequently improves whole body insulin
sensitivity [27].
So, obesity promoted - hyperinsulinemia stimulates
leptin release. Like other biological signaling pathways,
leptin appears to regulate its own receptor signaling or
increased central leptin results in reduced hypothalamic
leptin receptor expression and leptin signaling. Hence,
obesity promotes hyperleptinemia, which in turn self pro-
motes leptin resistance and further obesity, making leptin
resistance both a consequence and cause of obesity [27].
Thyroid dysfunction in DS
Thyroid dysfunction is highly prevalent in DS persons.
The clinical symptoms and signs of both DS and
hypothyroidism are overlapping to some extent e.g.
hypotonia, mental retardation, growth failure, macroglo-
sia, obesity etc. [28]. The presence of undetected
hypothyroidism in children with DS could compound
the problems in already compromised situation.
We observed significantly higher FT4 but not exceeding
reference range (1–5 years: 11.9 – 22.1; 6–10 years: 11.5-
19.96pmol/L) [29] with no significant difference in TSH
values in Down versus non Down groups. This was in
contrary to previous data reported by Konings et al. [4]
and Shaw et al. [28] who found higher mean TSH values
(6.5±1.3, 5.4±2.9mU/l respectively) in face of normal FT4
or T4. They hypothesized that thyroid gland in children
with DS needs an elevated TSH pressure to produce suffi-
cient hormones [4]. However, we observed elevated serum
TSH values with normal thyroxine levels in four cases,
three in OD and one in NOD groups denoting subclinical
hypothyroidism, associated with CK above 90U/l [30].
Hypotonia, CK & associated myopathy in DS children
Considering hypotonia as a risk factor for obesity in DS,
we suggest that it could be associated with musclebreakdown. CK is considered the primary marker for
muscle breakdown, in response to exercise, a portion of
the population has exaggerated increases in CK [31,32].
Reasons for an exaggerated response are not fully under-
stood but may reflect genetics [31], fiber type, an under-
lying myopathy, and/or some other environmental
behavioral factors, including fitness level [33]. Further-
more variations in muscle mass have been proposed to
account for interracial differences in total CK activity
[34]. Our results showed significantly higher median CK
value in OD compared with OND group. Also a positive
correlation was found between CK and TSH in OD
group. Associated myopathy either endocrine [35]
(hypothyroid related myopathy) or infectious secondary
to viral infection [36], strenuous physical activity [32]
may be the underlying causes for these mildly elevated
CK values and muscle weakness could be added to the
hypotonia which is a part of genetic predisposition of
the disease.
Conclusions
Increased circulating leptin, a marker of leptin resistance
in obese Down children seems to be similar to that in
children with simple obesity, this could point to an ab-
sence of genetic basis for more leptin resistance in such
high risk population for obesity. The association between
fasting hyperglycemia and hyperinsulinemia in obese
children with DS indicates early IR, suggesting a possible
genetic basis. Associated myopathy could be an added
factor for obesity as proved by the mildly elevated CK
values. Large sample size, studying other causes of DS
and further genetic study are needed to prove the gen-
etic role in this tendency for obesity in DS.
Limitations
The study was small in size, single center, cross sectional
comparative study. It relied solely on BMI for age per-
centiles of Center of Disease Control and Prevention as
an indicator of body fatness because it is simple, easily
obtained than skin folds thickness, presence of standar-
dized BMI curves and cut-off points defining overweight
& adiposity in childhood [37] and correlates well with
DEXA [38]. Previous results, suggest that skin fold mea-
surements may only slightly improve (8%) the estimation
of body fatness among children who are obese (BMI
≥95th CDC percentile) [39]. Furthermore it may help
determine if an overweight child may have excess body
fatness [39] and this group of children were not included
in our study. Finally due to racial variation and poor
inter- and intra- observer reliability skin fold thickness
equations should be validated in each population and it
is difficult to standardize [39]. While for waist circumfer-
ence, no internationally accepted cut points for either
the classification of obesity or presence of increased
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no data on population with DS can be found on this re-
gard [40]. Body fat itself is not necessarily a precise
measure of health risk. As stated by the recent AMA ex-
pert committee [41], “High levels of body fat are asso-
ciated with increasing health risks. However, no single
body fat value, whether measured as fat mass or as per-
centage of body weight, clearly distinguishes health from
disease or risk of disease”.
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